Khosla Ventures Acquisition Co. ( KVSA) Stock. Should you Buy or Sell? $ 9.81
0.00 (0.00 %)
Khosla Ventures Acquisition Co. AnalysisUpdated on 10-09-2022
|Volume Avg.||$156.14 thousand|
|Market Cap||$397.17 M|
|52 Week Range||$9.58 - $10.01|
Khosla Ventures Acquisition Co. opened the day at $9.81 which is 0.00 % on yesterday's close. Khosla Ventures Acquisition Co. has a 52 week high of $10.01 and 52 week low of $9.58, which is a difference of $0.43. We like to see positive, upward trending shares, preferably with momentum. Market capitalization is $397.17 M and total net profit is $0 which means the company is trading at inf times profit to market capitalization. Theoretically, if you were to buy Khosla Ventures Acquisition Co. for $397.17 M, it would take 15 years to get your money back. Khosla Ventures Acquisition Co. are in the Shell Companies space which will have a sweet spot and industry standard for net profit multiples.
Khosla Ventures Acquisition Co. Stock Forecast - Is Khosla Ventures Acquisition Co. a Buy or Sell?
|DCF Score||Strong Buy|
|PE Score||Strong Buy|
Growth and Value
|Net Profit Margin||0.000|
Valuing Khosla Ventures Acquisition Co.
|Price Book Value Ratio||0.178||Price To Book Ratio||0.178|
|Price To Sales Ratio||0.000||Price Earnings Ratio||-13.449|
How liquid is Khosla Ventures Acquisition Co.
|Debt Ratio||0.048||Debt Equity Ratio||0.051|
|Long Term Debt To Capitalization||0.000||Total Debt To Capitalization||0.000|
Latest news about Khosla Ventures Acquisition Co.
Neighborhood-oriented social network Nextdoor is entering the public markets via a SPAC merger with blank check company Khosla Ventures. Sarah Friar, Nextdoor CEO, joined Cheddar to discuss taking the IPO and how the company, already in one-in-three U.S. households, plans to expand both domestically and overseas.
Khosla Ventures/Valo Health De-SPAC: Heed The Sponsor's Advice And Stay Away
Boston-based Valo Health LLC has agreed to go public through a reverse merger with a blank-check firm backed by venture capitalist Vinod Khosla, in a deal valuing the combined company at about $2.8 billion. Founded in 2019, Valo Health is a biotech company that uses data analysis and artificial intelligence to help drug discovery and development.
Khosla Ventures Acquisition Co. (NASDAQ: KVSA), a special purpose acquisition vehicle (SPAC), and Valo Health LLC, a technology startup company, have entered into a definitive merger agreement to combine and take Valo Health public. Valo is a Boston-headquartered technology company that aims to accelerate the drug discovery and development process using its Opal Computational Platform […] The post The latest SPAC deal to know about: Valo Health to combine with Khosla Ventures Acquisition appeared first on Invezz.
About Khosla Ventures Acquisition Co.
Khosla Ventures Acquisition Co. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2021 and is based in Menlo Park, California.